MedPath

Association Between Sleep and Psychomotor Development in Early Childhood

Recruiting
Conditions
Sleep
Registration Number
NCT06816225
Lead Sponsor
Universidade do Porto
Brief Summary

Sleep is a neurophysiological active process essential for healthy physical and cognitive development. In Portugal, there is no recent and objective data on how children sleep.

Given the importance of sleep in child health and development as well as the health gains achieved by establishing healthy sleep patterns since childhood, it seems extremely relevant to assess the various sleep parameters of Portuguese children and correlate them with their psychomotor and anthropometric development indicators. The results of this research work may support the implementation of sleep health education measures among parents, educators and policy makers, thus contributing to support the implementation of practices that promote sleep quality, napping until later in life as well as to promote the health of future adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
119
Inclusion Criteria
  • Children aged 2 and 6 months year until the first assessment;
  • Gestational age at birth 37 weeks or more;
  • Delivery without serious complications for the child;
  • Absence of developmental pathologies or pathologies that interfere with psychic and motor development;
Exclusion Criteria
  • Non-preterm birth but with severe growth restriction;
  • Diagnosis of psychomotor development pathology;
  • Diagnosis of pathology that interferes with psychomotor development;
  • Taking daily medication, except vitamin supplements.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sleep hygieneAt 24 - 30 months of age, at 3 years of age and at 4 years of age

Sleep hygiene data obtained through the application of the Children Sleep habits questionnaire validated for the Portuguese population.

Sleep patternsAt 24 - 30 months of age, at 3 years of age and at 4 years of age

Sleep patterns based on movement tracking by sleep actigraphy.

Psychomotor developmentAt 24 - 30 months of age, at 3 years of age and at 4 years of age

The psychomotor developmental coefficient obtained through the application of the evaluation tool Schedule of growing skills II (SGS II) development scale.

Melatonin levelsAt 24 - 30 months of age, at 3 years of age and at 4 years of age

Levels of 6-sulphatoxymelatonin-aMT6, melatonin metabolite, measured in urine.

Secondary Outcome Measures
NameTimeMethod
Body Mass Index [BMI]At 24 - 30 months of age, at 3 years of age and at 4 years of age

Weight \[kg, kilogram\] and height \[m, meter\] at the date of the evaluation for BMI-for-age calculation

Number of infectious eventsAt 24 - 30 months of age, at 3 years of age and at 4 years of age

Number of infectious events in the first year of life and previous year of the following assessments.

Trial Locations

Locations (1)

Faculty of Medicine (FMUP)

🇵🇹

Porto, Portugal

© Copyright 2025. All Rights Reserved by MedPath